Peter Zdziarski: A Brighter Future for Glanzmann Thrombasthenia Through Gene Therapy
Peter Zdziarski, Vice President and Marketing Director at Glanzmann’s Research Foundation, shared a post on LinkedIn։
“It’s Rare Disease Day, and tomorrow is the official Glanzmann Thrombasthenia Awareness Day.
I was born with GT, and knowing that I may see gene therapy in my lifetime is incredible.
Through every challenge and every win, I wouldn’t change my journey.
The people I’ve met, the knowledge I’ve gained, and the places this path has taken me have shaped who I am, and I’m truly grateful.
Please consider donating to the Medical College of Wisconsin.
Every contribution moves us closer to a future where people with GT have more than just a couple of treatment options.
But a true solution.
A future with fewer antibodies from platelet transfusions, fewer dangerous bleeds, less bruising, and fewer long hospital stays.
The future is bright.
Donate toward gene therapy.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026
-
Jun 4, 2026, 15:25Heba Youssef: Anticoagulation Bridging – A Clinical Summary Every Practitioner Should Know
-
Jun 4, 2026, 15:10Dipanjana Datta: Genetic Spectrum of Hemophilia and Carrier Screening in Families of Persons with Hemophilia